FundedIQ
Health Care

ViCentra: Funding, Investors & Team (Sep 2026)

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

www.hellokaleido.com LinkedIn Utrecht, Netherlands 51-100 employees
Health Care Medical Medical Device
Total raised
$86.6M
Rounds
2
Latest
Series D
Jan 2026

ViCentra has raised $86.6M across 2 funding rounds on record, the most recent a Series D of $13.0M announced in Jan 2026.

That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.

ViCentra Company Profile and Key Stats

Total funding raised
$86.6M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series D
$13.0M in Jan 2026
Employees
51-100
reported band
Headquarters
Utrecht, Netherlands

Latest funding round on record: Jan 2026.

ViCentra Funding Rounds

Date
Round
Amount
Series D
$13.0M
Series C
$73.6M

ViCentra raised $73.6M in a Series C announced in Dec 2021.

4.1 years later, a Series D of $13.0M was announced in Jan 2026.

ViCentra Founders and Leadership Team

Name
Role
Contact
Tim Oakes
Founder
Frans Cromme
CEO
Locked

Contact details for the ViCentra team: 1 of 2 have an email address on file.

Start 14-day free trial →

ViCentra Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,653
$4.7M
740
$5.0M
760
$90M

ViCentra's latest round of $13.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like ViCentra in Health Care and Utrecht

Companies Similar to ViCentra

The most cutting-edge polymer-based platform of restorative cardiovascular devices was created by Xeltis.…

Undisclosed round $23.3M

Vitestro revolutionizes the way patients are cared for by introducing independent blood-drawing technology.

Series B $70.0M

Speaklee is a company that utilizes AI technology to create a speech assistant tool for children who have…

Undisclosed round $410k

CardiacBooster is a company in the medical field that creates percutaneous devices to assist the left…

Undisclosed round $10.8M

Plasmacure offers a patented cold plasma solution designed to heal chronic wounds. They provide services in…

Series A $7.1M

Hy2Care® is a company that originated from the MIRA Institute at the University Twente in the Netherlands, a…

Undisclosed round $5.0M

Platos Health is a technology startup dedicated to increasing access to preventive healthcare. Our current…

Pre-Seed $1.4M

AVIGI Therapeutics is leading the way in creating new drugs through a rational approach that combines…

Pre-Seed $380k
Seed $1.1M

Sirius medical helps in improving healthcare for cancer patients by developing medical devices that helps in…

Undisclosed round $10.3M

PROBLEM Insufficient treatment of vulnerable plaque in the coronary arteries lead to costly and health…

Undisclosed round $2.5M

Vico Therapeutics specializes in creating RNA-modulating treatments for rare neurological conditions. The…

Series B $12.3M

ViCentra Funding FAQs

What does ViCentra do?

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

How much funding has ViCentra raised?

ViCentra has raised $86.6M across 2 rounds on record. The most recent is a Series D of $13.0M announced in Jan 2026.

When did ViCentra last raise funding?

ViCentra's most recent funding round on record is a Series D of $13.0M, announced in Jan 2026.

Who founded ViCentra?

FundedIQ lists Tim Oakes (Founder) at ViCentra.

Who is the CEO of ViCentra?

Frans Cromme is listed as CEO at ViCentra.

Where is ViCentra headquartered?

ViCentra is based in Utrecht, Netherlands.

How many employees does ViCentra have?

ViCentra is in the 51-100 employee band.

How does ViCentra's funding compare to other Health Care startups?

ViCentra's latest round of $13.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.

About FundedIQ's ViCentra Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ViCentra is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.